Abstract.
Presented here is the case of a paraneoplastic cerebral degeneration (PCD) in a female patient with breast cancer and the indication of anti-Yo antibodies in the cerebrospina fluid (CSF) and serum. The patient's primary indications were dizziness and a severe gait ataxia. The indication of anti-Yo antibodies led to the conclusion of the existence of a paraneoplastic cerebral degeneration. The antibodies in question are anti-Purkinje-cell autoantibodies acting against the antigens common to tumor and Purkinje cells which occur in association with a certain percentage of breast or ovarian cancers. The diagnosis of the primary tumor, that is clinically undetectable with conventional imaging processes, is performed with the aid of positron emission tomography (PET) to detect the presence of axillary lymph node metastases. The micro-invasive mammary carcinoma was able to be localized with the aid of MR mammography and, after MR mammography marking, was removed. The patient subsequently received adjuvant treatment with epirubicine and cyclophosphamide. This treatment failed to influence the paraneoplastic neurological symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amyes E, Curnow J, Stark Z, Corlett L, Sutton I, Vincent A (2001) Restricted IgG 1 subclasses of anti-Yo antibodies in paraneoplastic cerebellar degeneration. J Neuroimmunol 114:259–264
Antoine JC, Honnorat J (2000) Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology. Rev Neurol 156:23–33
Bolla L, Palmer RM (1997) Paraneoplastic cerebellar degeneration. Arch Intern Med 157:1258–1262
Cao Y, Abbas J, Wu X, Dooley J, van Amburg AL (1999) Anti-Yo-positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. Gynecol Oncol 75:178–183
Dalmau J, Posner JB (1994) Neurologic paraneoplastic antibodies (anti-Yo, anti-Hu, anti-Ri). Neurology 44:2241–2246
Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322:1844–1851
Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM (2001) Antibody types and IgG subclasses in paraneoplastic neurological syndromes. J Neurol Sci 184:131–137
Holzmann P, Holy D, Stillhard G, Janda M, Möhr P (1998) Paraneoplastische zerebelläre Degeneration (PCD) mit Anti Yo-Antikörpern bei Ovarialkarzinom. Schweiz Med Wochenschr 128:906–908
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G (1996) Paraneoplastische zerebelläre Degeneration: Fallbeobachtung einer Patientin mit Mammakarzinom. Geburtsh Frauenheilk 56:214–216
Johns JB, Odunsi KO, Fleischmann S, Azodi M, Schwartz PE (1999) Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration. Gynecol Oncol 73:326–330
Keime-Guibert F, Graus F, Fleury A, Rene R, Honnorat J, Broet P, Delattre J-Y (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479–482
Kurokawa T, Taniwaki T, Arakawa K, Kikuchi H, Yao T, Tanaka K, Yamanda T, Kira J (2001) A case of paraneoplastic cerebellar degeneration with resting tremor. Rinsho Shinkeigaku 41:24–30
Meglic B, Graus F, Grad A (2001) Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci 185:135–138
Moll JWB, Hooijkaas H, van Goorbergh BCM, Roos LGE, Henzen-Logmans SC, Vecht CJ (1996) Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease. J Neurol 243:51–56
Peltola J, Hietaharju A, Rantala I, Lehtinen T, Haapasalo H (1998) A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease. Acta Neurol Scand 98:360–363
Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S (1994) Passive transfer and active immunisation with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 127:153–158
Tanaka M, Tanaka K, Idezuka J, Tsuji S (1998) Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Exp Neurol 150:337–338
Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S (1998) Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 161:88–90
Waterhouse DM, Natale RB, Cody RL (1991) Breast cancer and paraneoplastic cerebellar degeneration. Cancer 68:1835–1841
Author information
Authors and Affiliations
Additional information
The first two authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Dorn, C., Knobloch, C., Kupka, M. et al. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report. Arch Gynecol Obstet 269, 62–65 (2003). https://doi.org/10.1007/s00404-002-0416-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-002-0416-2